Curcumin and liver cancer: A review

Altaf S. Darvesha, Bharat B. Aggarwal, Anupam Bishayee

Research output: Contribution to journalReview article

  • 125 Citations

Abstract

Primary liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most lethal cancers having worldwide prevalence. Although most HCC cases are reported in the developing countries of Asia and Africa, there has been an alarming increase in HCC cases in Western Europe as well as United States. Chronic liver diseases, viral hepatitis, alcoholism as well as dietary carcinogens, such as aflatoxins and nitrosoamines, contribute to HCC. Liver transplantation as well as surgical resection at best offer limited treatment options. Thus, there exists a critical need to investigate and evaluate possible alternative chemopreventive and therapeutic strategies which may be effective in the control of liver cancer. HCC, most often, develops and progresses in a milieu of oxidative stress and inflammation. Phytochemicals, such as dietary polyphenols endowed with potent antioxidant as well as anti-inflammatory properties, provide a suitable alternative in affording alleviation of HCC. Curcumin, the principal polyphenolic curcuminoid, obtained from the turmeric rhizome Curcuma longa has long been used to cure several chronic ailments, such as neoplastic and neurodegenerative diseases. Studies suggest that curcumin may have antitumor, antioxidant, and anti-inflammatory properties. This article reviews the effects of curcumin in preclinical in vitro and in vivo models of HCC with particular emphasis to its antioxidant, apoptotic and anti-inflammatory effects as well as involvement in various molecular signaling mechanisms. This review also discusses potential challenges involved in the use of curcumin in HCC, such as bioavailability, pharmacokinetics, drug delivery as well as paucity of clinical studies.

LanguageEnglish (US)
Pages218-228
Number of pages11
JournalCurrent Pharmaceutical Biotechnology
Volume13
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Curcumin
Liver Neoplasms
Hepatocellular Carcinoma
Curcuma
Anti-Inflammatory Agents
Antioxidants
Rhizome
Aflatoxins
Phytochemicals
Polyphenols
Neurodegenerative Diseases
Carcinogens
Liver Transplantation
Hepatitis
Biological Availability
Developing Countries
Alcoholism
Liver Diseases
Oxidative Stress
Chronic Disease

Keywords

  • Chemoprevention
  • Curcumin
  • Inflammation
  • Liver cancer
  • Oxidative stress
  • Therapy

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Biotechnology

Cite this

Darvesha, A. S., Aggarwal, B. B., & Bishayee, A. (2012). Curcumin and liver cancer: A review. Current Pharmaceutical Biotechnology, 13(1), 218-228. https://doi.org/10.2174/138920112798868791

Curcumin and liver cancer : A review. / Darvesha, Altaf S.; Aggarwal, Bharat B.; Bishayee, Anupam.

In: Current Pharmaceutical Biotechnology, Vol. 13, No. 1, 01.2012, p. 218-228.

Research output: Contribution to journalReview article

Darvesha, AS, Aggarwal, BB & Bishayee, A 2012, 'Curcumin and liver cancer: A review' Current Pharmaceutical Biotechnology, vol. 13, no. 1, pp. 218-228. https://doi.org/10.2174/138920112798868791
Darvesha, Altaf S. ; Aggarwal, Bharat B. ; Bishayee, Anupam. / Curcumin and liver cancer : A review. In: Current Pharmaceutical Biotechnology. 2012 ; Vol. 13, No. 1. pp. 218-228.
@article{929a5e7ac5ee40ac96245e222becc25f,
title = "Curcumin and liver cancer: A review",
abstract = "Primary liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most lethal cancers having worldwide prevalence. Although most HCC cases are reported in the developing countries of Asia and Africa, there has been an alarming increase in HCC cases in Western Europe as well as United States. Chronic liver diseases, viral hepatitis, alcoholism as well as dietary carcinogens, such as aflatoxins and nitrosoamines, contribute to HCC. Liver transplantation as well as surgical resection at best offer limited treatment options. Thus, there exists a critical need to investigate and evaluate possible alternative chemopreventive and therapeutic strategies which may be effective in the control of liver cancer. HCC, most often, develops and progresses in a milieu of oxidative stress and inflammation. Phytochemicals, such as dietary polyphenols endowed with potent antioxidant as well as anti-inflammatory properties, provide a suitable alternative in affording alleviation of HCC. Curcumin, the principal polyphenolic curcuminoid, obtained from the turmeric rhizome Curcuma longa has long been used to cure several chronic ailments, such as neoplastic and neurodegenerative diseases. Studies suggest that curcumin may have antitumor, antioxidant, and anti-inflammatory properties. This article reviews the effects of curcumin in preclinical in vitro and in vivo models of HCC with particular emphasis to its antioxidant, apoptotic and anti-inflammatory effects as well as involvement in various molecular signaling mechanisms. This review also discusses potential challenges involved in the use of curcumin in HCC, such as bioavailability, pharmacokinetics, drug delivery as well as paucity of clinical studies.",
keywords = "Chemoprevention, Curcumin, Inflammation, Liver cancer, Oxidative stress, Therapy",
author = "Darvesha, {Altaf S.} and Aggarwal, {Bharat B.} and Anupam Bishayee",
year = "2012",
month = "1",
doi = "10.2174/138920112798868791",
language = "English (US)",
volume = "13",
pages = "218--228",
journal = "Current Pharmaceutical Biotechnology",
issn = "1389-2010",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Curcumin and liver cancer

T2 - Current Pharmaceutical Biotechnology

AU - Darvesha, Altaf S.

AU - Aggarwal, Bharat B.

AU - Bishayee, Anupam

PY - 2012/1

Y1 - 2012/1

N2 - Primary liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most lethal cancers having worldwide prevalence. Although most HCC cases are reported in the developing countries of Asia and Africa, there has been an alarming increase in HCC cases in Western Europe as well as United States. Chronic liver diseases, viral hepatitis, alcoholism as well as dietary carcinogens, such as aflatoxins and nitrosoamines, contribute to HCC. Liver transplantation as well as surgical resection at best offer limited treatment options. Thus, there exists a critical need to investigate and evaluate possible alternative chemopreventive and therapeutic strategies which may be effective in the control of liver cancer. HCC, most often, develops and progresses in a milieu of oxidative stress and inflammation. Phytochemicals, such as dietary polyphenols endowed with potent antioxidant as well as anti-inflammatory properties, provide a suitable alternative in affording alleviation of HCC. Curcumin, the principal polyphenolic curcuminoid, obtained from the turmeric rhizome Curcuma longa has long been used to cure several chronic ailments, such as neoplastic and neurodegenerative diseases. Studies suggest that curcumin may have antitumor, antioxidant, and anti-inflammatory properties. This article reviews the effects of curcumin in preclinical in vitro and in vivo models of HCC with particular emphasis to its antioxidant, apoptotic and anti-inflammatory effects as well as involvement in various molecular signaling mechanisms. This review also discusses potential challenges involved in the use of curcumin in HCC, such as bioavailability, pharmacokinetics, drug delivery as well as paucity of clinical studies.

AB - Primary liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most lethal cancers having worldwide prevalence. Although most HCC cases are reported in the developing countries of Asia and Africa, there has been an alarming increase in HCC cases in Western Europe as well as United States. Chronic liver diseases, viral hepatitis, alcoholism as well as dietary carcinogens, such as aflatoxins and nitrosoamines, contribute to HCC. Liver transplantation as well as surgical resection at best offer limited treatment options. Thus, there exists a critical need to investigate and evaluate possible alternative chemopreventive and therapeutic strategies which may be effective in the control of liver cancer. HCC, most often, develops and progresses in a milieu of oxidative stress and inflammation. Phytochemicals, such as dietary polyphenols endowed with potent antioxidant as well as anti-inflammatory properties, provide a suitable alternative in affording alleviation of HCC. Curcumin, the principal polyphenolic curcuminoid, obtained from the turmeric rhizome Curcuma longa has long been used to cure several chronic ailments, such as neoplastic and neurodegenerative diseases. Studies suggest that curcumin may have antitumor, antioxidant, and anti-inflammatory properties. This article reviews the effects of curcumin in preclinical in vitro and in vivo models of HCC with particular emphasis to its antioxidant, apoptotic and anti-inflammatory effects as well as involvement in various molecular signaling mechanisms. This review also discusses potential challenges involved in the use of curcumin in HCC, such as bioavailability, pharmacokinetics, drug delivery as well as paucity of clinical studies.

KW - Chemoprevention

KW - Curcumin

KW - Inflammation

KW - Liver cancer

KW - Oxidative stress

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84855841781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855841781&partnerID=8YFLogxK

U2 - 10.2174/138920112798868791

DO - 10.2174/138920112798868791

M3 - Review article

VL - 13

SP - 218

EP - 228

JO - Current Pharmaceutical Biotechnology

JF - Current Pharmaceutical Biotechnology

SN - 1389-2010

IS - 1

ER -